Single-dose treatment shows effectiveness for Indian visceral leishmaniasis.
Pirisi
A
A
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001416:Back Pain / Q000139:chemically induced; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced
D000981:Antiprotozoal Agents; D000666:Amphotericin B